Riskpilot← Back to searchSign inGet full accessADUND AS
ASActiveOrg 915193684Trosterudveien 34B, 0778 OsloGeneral medical practice activities · NACE 8621Est. 20151 employees
Revenue 2024
NOK 3,6M
+4% vs 2023
EBITDA margin
43.8%
-5% vs 2023
Equity ratio
75.1%
Financial strength
Net profit 2024
NOK 2,3M
+25% vs 2023
| Revenue | NOK 3,6M | +4% |
| EBITDA | NOK 1,6M | -5% |
| Net profit | NOK 2,3M | +25% |
| Total assets | NOK 6,4M | +29% |
| Equity | NOK 4,8M | +24% |
| Employees | 1 | — |
Legal name
ADUND AS
Org number
915193684
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
7. april 2015
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet, utarbeidelse av spesialisterklæringer og sakkyndige oppdrag, konsulentvirksomhet, turneringssjakk og kurs-/undervisningsvirksomhet i tilknytning til dette, samt forvaltning av selskapets kapital og ressurser i form av investeringsvirksomhet, deltakelse i andre selskaper, finansforvaltning og kjøp/drift av fast eiendom.
Address
Trosterudveien 34B, 0778 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 751 | 3 101 | 3 350 | 3 504 | 3 641 |
| Staff expenses | −876 | −921 | −807 | −815 | −905 |
| EBITDA | 957 | 1 169 | 1 476 | 1 677 | 1 594 |
| Depreciation & amort. | −183 | −174 | −174 | −174 | −117 |
| EBIT | 774 | 995 | 1 302 | 1 503 | 1 478 |
| Net financials | 9 | 397 | −276 | 714 | 1 197 |
| Profit before tax | 783 | 1 391 | 1 026 | 2 216 | 2 675 |
| Tax | 172 | 219 | 301 | 354 | 341 |
| Net profit | 611 | 1 172 | 725 | 1 863 | 2 334 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 771 | 4 386 | 3 923 | 4 972 | 6 419 |
| Equity | 3 129 | 2 401 | 2 626 | 3 889 | 4 822 |
| Long-term debt | 18 | 4 | 0 | 0 | 0 |
| Short-term debt | 625 | 1 981 | 1 297 | 1 083 | 1 596 |
| Total debt | 643 | 1 985 | 1 297 | 1 083 | 1 596 |
EBITDA margin
43.8%
This company
15.8%
Market median
+177% vs market
20202024
Equity ratio
75.1%
This company
38.2%
Market median
+97% vs market
20202024
Return on equity
48.4%
This company
18.4%
Market median
+163% vs market
20202024
Net profit margin
64.1%
This company
8.1%
Market median
+691% vs market
20202024
Asset turnover
0.57×
This company
1.12×
Market median
-49% vs market
20202024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FE Chief Executive Officer | Chief Executive Officer | 2015 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ADUND AS 
ALEFE ASBoard members of ADUND AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frode Elsness | Chief Executive Officer | 0 companies |